China Halometasone Cream Localized Neurodermatitis, Nummular Dermatitis and Psoriasis Vulgaris, Find details about China Health Care, Bone from Halometasone Cream Localized Neurodermatitis, Nummular Dermatitis and Psoriasis Vulgaris
Name | Halometasone Cream | |||||||||
Ingredient | The main component of this product is halometasone monohydrate. | |||||||||
Form | This product is a white cream | |||||||||
Function | A non-infectious inflammatory skin disease that is effective for corticosteroid therapy. Such as seborrheic dermatitis, contact dermatitis, atopic dermatitis, localized neurodermatitis, nummular dermatitis and psoriasis vulgaris. | |||||||||
Usage and dosage | Apply a thin layer to the affected area once or twice a day depending on the symptoms, and rub gently; if necessary, use a porous bandage to wrap the affected area, usually without a sealed bandage. For those with poor efficacy or stubborn patients, a short-term sealing bandage can be used to enhance the efficacy. For chronic skin diseases (such as psoriasis or chronic eczema), this product should not be stopped suddenly when using this product. It should be replaced with an emollient or another corticosteroid with weaker efficacy, and the dosage of this product should be gradually reduced. | |||||||||
Untoward reaction and Contraindication | Occasionally: irritation at the site of application, such as burning and itching. Rare: dry skin, erythema, skin atrophy, folliculitis, acne or pus. If severe irritation or allergic symptoms have occurred, treatment should be terminated. It has been reported that the adverse reactions of topical medication include: contact allergy, skin pigmentation or secondary infection. In addition, especially in long-term use, or for large areas of skin or sealing bandages, or for areas with high permeability such as the face and underarms, lines of atrophy, atrophic changes, bleeding, and perioral dermatitis may occur. Or rosacea-like dermatitis, telangiectasia, purpura, or hormonal acne. When using a large area for external use or using a sealed bandage (especially for newborns or young children), corticosteroids can enter the blood circulation and produce systemic effects (especially temporary suppression of adrenal function). These effects disappear after stopping this product However, if the drug is stopped suddenly, acute adrenal insufficiency may occur. 1. Those who are allergic to any ingredient of this product. 2. Bacterial and viral skin diseases (such as chickenpox, pyoderma, post-vaccination, herpes simplex, herpes zoster), fungal skin diseases, syphilitic skin lesions, skin tuberculosis, rosacea, perioral dermatitis, acne vulgaris patient. | |||||||||
Precautions | Regardless of the age of the patient, long-term continuous use should be avoided, and hermetic dressing should be limited to short-term and small areas of skin. If you use this product in large doses for special needs, or apply it to a large area of skin, or use a sealed dressing, or use it for a long time, the patient should be subject to regular medical examinations. This product should be used with caution on the face or rubbed areas (such as the axillary area), and should only be used for a short period of time. No systemic adverse reactions have been reported, such as the effect on adrenal cortex function. However, according to the basic medical theory, this danger is not ruled out. When using this product under the following conditions, such as: when using a sealed dressing on a large area of skin (especially in pediatrics), if the skin is infected with the drug, it should be treated with appropriate antibacterial immediately. This product should not be in contact with the conjunctiva or mucous membrane of the eye. Corticosteroids can mask allergic skin reactions caused by a certain ingredient in this product. Patients should be warned that this medicine can only be used for their own current skin diseases and not for other people. Medication for pregnant and lactating women: The safety evaluation of corticosteroids has been carried out, and the animal experiment with halometasone has been carried out. The experiment has proved that it may be potentially teratogenic or have other adverse effects on embryos and/or young fetuses. Pregnant women must pay attention to weighing the pros and cons when using this product, and should have clear indications for treatment, and should not be used in large doses, and should not be used on large areas of skin (especially should not be used for sealing bandages) or long-term use. It is not clear whether the active substance of this product and/or its metabolites are secreted into milk. Women who are breastfeeding should use it with caution. Children's medication: For young children and children, avoid long-term continuous treatment to avoid the occurrence of adrenal axis suppression. Continuous treatment should not exceed two weeks; for children under 2 years of age, treatment should not exceed seven days. The skin area of the dressing should not exceed 10% of the body surface area, and a sealed bandage should not be used. | |||||||||
Drug interaction | If it is used with other drugs at the same time, drug interaction may occur. Please consult your physician or pharmacist for details. |